134 related articles for article (PubMed ID: 14973052)
1. Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.
Lengagne R; Le Gal FA; Garcette M; Fiette L; Ave P; Kato M; Briand JP; Massot C; Nakashima I; Rénia L; Guillet JG; Prévost-Blondel A
Cancer Res; 2004 Feb; 64(4):1496-501. PubMed ID: 14973052
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
Pommier A; Audemard A; Durand A; Lengagne R; Delpoux A; Martin B; Douguet L; Le Campion A; Kato M; Avril MF; Auffray C; Lucas B; Prévost-Blondel A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13085-90. PubMed ID: 23878221
[TBL] [Abstract][Full Text] [Related]
3. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
Byrne KT; Zhang P; Steinberg SM; Turk MJ
J Immunol; 2014 Feb; 192(4):1433-9. PubMed ID: 24403535
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.
Byrne KT; Côté AL; Zhang P; Steinberg SM; Guo Y; Allie R; Zhang W; Ernstoff MS; Usherwood EJ; Turk MJ
J Clin Invest; 2011 May; 121(5):1797-809. PubMed ID: 21540555
[TBL] [Abstract][Full Text] [Related]
6. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prévost-Blondel A
J Immunol; 2008 Jan; 180(1):130-7. PubMed ID: 18097012
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
8. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Ramacher M; Umansky V; Efferth T
Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D
Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920
[TBL] [Abstract][Full Text] [Related]
10. Dormant tumor cells interact with memory CD8
Flores-Guzmán F; Utikal J; Umansky V
Cancer Lett; 2020 Apr; 474():74-81. PubMed ID: 31962142
[TBL] [Abstract][Full Text] [Related]
11. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
[TBL] [Abstract][Full Text] [Related]
12. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
You S; Cho YH; Byun JS; Shin EC
Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
[TBL] [Abstract][Full Text] [Related]
13. Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.
Umansky V; Sevko A
Pigment Cell Melanoma Res; 2013 Jul; 26(4):457-63. PubMed ID: 23560814
[TBL] [Abstract][Full Text] [Related]
14. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
Kato M; Liu W; Akhand AA; Dai Y; Ohbayashi M; Tuzuki T; Suzuki H; Isobe K; Takahashi M; Nakashima I
Oncogene; 1999 Jan; 18(3):837-42. PubMed ID: 9989837
[TBL] [Abstract][Full Text] [Related]
15. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
[TBL] [Abstract][Full Text] [Related]
16. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
[TBL] [Abstract][Full Text] [Related]
17. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin.
Lane C; Leitch J; Tan X; Hadjati J; Bramson JL; Wan Y
Cancer Res; 2004 Feb; 64(4):1509-14. PubMed ID: 14973051
[TBL] [Abstract][Full Text] [Related]
18. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
20. T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice.
Dai Y; Kato M; Takeda K; Kawamoto Y; Akhand AA; Hossain K; Suzuki H; Nakashima I
J Invest Dermatol; 2001 Sep; 117(3):694-701. PubMed ID: 11564179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
